était pratiqué pour tous les patients par le modèle Cirrus (Carl Zeiss Meditec, Dublin, California) afin d'obtenir l'épaisseur maculaire moyenne des 1 mm centraux (EMM) ,
la PIO s'est élevée 3 fois plus que dans le groupe ne présentant pas d ,
Degree, duration, and causes of visual loss in uveitis, British Journal of Ophthalmology, vol.88, issue.9, pp.1159-62, 2004. ,
DOI : 10.1136/bjo.2003.037226
Rapport de la Société Française d'Ophtalmologie, 2010. ,
The possible impact of uveitis in blindness: a literature survey., British Journal of Ophthalmology, vol.80, issue.9, pp.844-852, 1996. ,
DOI : 10.1136/bjo.80.9.844
Cystoid Macular Edema in Uveitis, Dev Ophthalmol, vol.47, pp.136-183, 2010. ,
DOI : 10.1159/000320077
Dexamethasone for ocular inflammation, Expert Opinion on Pharmacotherapy, vol.124, issue.7, pp.1127-1158, 2011. ,
DOI : 10.1001/archopht.125.11.ecs70063
General pathophysiology of macular edema, European Journal of Ophthalmology, vol.21, issue.Suppl. 6, pp.10-19, 2011. ,
DOI : 10.5301/EJO.2010.6050
Rétine -Inflammation, 2012. ,
Anatomie de la r??tine, EMC - Ophtalmologie, vol.6, issue.1, pp.1-14, 2009. ,
DOI : 10.1016/S0246-0343(09)30048-9
Oedème maculaire (hors diabète), EMC -Ophtalmol, vol.11, issue.2, pp.1-21, 2014. ,
Société française d'ophtalmologie. Décollements de rétine rapport 2011, 2011. ,
The Therapeutic Potential of Intraocular Depot Steroid Systems. Dtsch Ärztebl Int, pp.584-90, 2012. ,
The M??ller cell: a functional element of the retina, Trends in Neurosciences, vol.19, issue.8, pp.307-319, 1996. ,
DOI : 10.1016/0166-2236(96)10040-0
Differential expression of Kir4.1 and aquaporin 4 in the retina from endotoxin-induced uveitis rat, Mol Vis, vol.13, pp.309-326, 2007. ,
Pathomechanisms of Cystoid Macular Edema, Ophthalmic Research, vol.36, issue.5, pp.241-250, 2004. ,
DOI : 10.1159/000081203
Clinical Review: Update on Treatment of Inflammatory Macular Edema, Ocular Immunology and Inflammation, vol.224, issue.6, pp.75-83, 2011. ,
DOI : 10.1080/09273940701244509
M??ller cells as players in retinal degeneration and edema, Graefe's Archive for Clinical and Experimental Ophthalmology, vol.6, issue.5, pp.627-663, 2007. ,
DOI : 10.1007/s00417-006-0516-y
The pathogenesis and clinical presentation of macular edema in inflammatory diseases, Doc Ophthalmol Adv Ophthalmol, vol.97, pp.3-4297, 1999. ,
DOI : 10.1007/978-94-011-4152-9_10
Macular Edema ??? Rationale for Therapy, Dev Ophthalmol, vol.47, pp.49-58, 2010. ,
DOI : 10.1159/000320073
Risk factors for cystoid macular oedema in patients with uveitis, Eye, vol.8, issue.2, pp.256-60, 2008. ,
DOI : 10.1038/sj.eye.6702595
Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis, Clinical Ophthalmology, vol.7, pp.1109-1153, 2013. ,
DOI : 10.2147/OPTH.S40268
Intravitreal Steroids for the Treatment of Retinal Diseases, The Scientific World Journal, vol.31, issue.6, p.989501, 2014. ,
DOI : 10.1097/IAE.0b013e318188c814
Intraocular Pressure Monitoring Post Intravitreal Steroids: A Systematic Review, Survey of Ophthalmology, vol.58, issue.4, pp.291-310, 2013. ,
DOI : 10.1016/j.survophthal.2012.08.003
Dexamethasone intravitreal implant for the treatment of noninfectious uveitis, Clin Ophthalmol Auckl NZ, vol.5, pp.1613-1634, 2011. ,
Trabecular Meshwork and Lens Partitioning of Corticosteroids, Archives of Ophthalmology, vol.129, issue.7, pp.914-934, 2011. ,
DOI : 10.1001/archophthalmol.2011.39
Genomic and nongenomic effects of glucocorticoids, Nature Clinical Practice Rheumatology, vol.149, issue.10, pp.525-558, 2008. ,
DOI : 10.1038/ncprheum0898
Early Effects of Intravitreal Triamcinolone on Macular Edema, Ophthalmology, vol.113, issue.11, 2006. ,
DOI : 10.1016/j.ophtha.2006.05.037
Clinical applications of the sustainedrelease dexamethasone implant for treatment of macular edema, Clin Ophthalmol Auckl NZ, vol.5, pp.139-185, 2011. ,
Outcome of Raised Intraocular Pressure in Uveitic Eyes with and without a Corticosteroid-Induced Hypertensive Response, American Journal of Ophthalmology, vol.148, issue.2 ,
DOI : 10.1016/j.ajo.2009.02.032
Vitreous concentrations of triamcinolone acetonide in human eyes after intravitreal or subtenon injection, American Journal of Ophthalmology, vol.138, issue.6, pp.1046-1054, 2004. ,
DOI : 10.1016/j.ajo.2004.05.028
New Developments in Corticosteroid Therapy for Uveitis, Ophthalmologica, vol.224, issue.1, pp.46-53, 2010. ,
DOI : 10.1159/000318021
Osteoporosis in the home health care setting: A window of opportunity? Arthritis Rheum, pp.971-976, 2006. ,
Complications and Safety Profile of Posterior Subtenon Injection of Triamcinolone Acetonide, Journal of Ocular Pharmacology and Therapeutics, vol.25, issue.2, pp.159-62, 2009. ,
DOI : 10.1089/jop.2008.0087
Outcome of Intravitreal Triamcinolone in Uveitis, Ophthalmology, vol.112, issue.11, pp.1916-1917, 2005. ,
DOI : 10.1016/j.ophtha.2005.06.009
Review and update of intraocular therapy in noninfectious uveitis, Current Opinion in Ophthalmology, vol.22, issue.6, pp.517-539, 2011. ,
DOI : 10.1097/ICU.0b013e32834bbd68
Treatment of posterior uveitis with a fluocinolone acetonide implant: three-year clinical trial results, Arch Ophthalmol, vol.126, issue.9, pp.1191-201, 2008. ,
Intraocular Methotrexate in the Treatment of Uveitis and Uveitic Cystoid Macular Edema, Ophthalmology, vol.116, issue.4, 2009. ,
DOI : 10.1016/j.ophtha.2008.10.033
Efficacy of interferon alpha in the treatment of refractory and sight threatening uveitis: a retrospective monocentric study of 45 patients, British Journal of Ophthalmology, vol.91, issue.3, pp.335-344, 2007. ,
DOI : 10.1136/bjo.2006.101550
Short-term Results of a Single Intravitreal Bevacizumab (Avastin) Injection versus a Single Intravitreal Triamcinolone Acetonide (Kenacort) Injection for the Management of Refractory Noninfectious Uveitic Cystoid Macular Edema, Ocular Immunology and Inflammation, vol.114, issue.6, 2009. ,
DOI : 10.1016/S0161-6420(02)00975-2
Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema. Retina Phila Pa, pp.111-119, 2011. ,
Octreotide Long-Acting Repeatable for the Treatment of Chronic Macular Edema in Uveitis, American Journal of Ophthalmology, vol.144, issue.6, pp.838-881, 2007. ,
DOI : 10.1016/j.ajo.2007.07.039
A pilot study of normative data for macular thickness and volume measurements using cirrus high-definition optical coherence tomography. Retina Phila Pa, pp.1944-50, 2011. ,
Dexamethasone Intravitreal Implant in the Treatment of Persistent Uveitic Macular Edema in the Absence of Active Inflammation. Ophthalmology, 2014. ,
Dexamethasone Intravitreal Implant: An Effective Adjunctive Treatment for Recalcitrant Noninfectious Uveitis, Ophthalmologica, vol.228, issue.4, pp.229-262, 2012. ,
DOI : 10.1159/000343060
Treatment of noninfectious posterior uveitis with dexamethasone intravitreal implant, Clin Ophthalmol Auckl NZ, vol.4, pp.1423-1429, 2010. ,
Treatment with Repeat Dexamethasone Implants Results in Long-Term Disease Control in Eyes with Noninfectious Uveitis, Ophthalmology, vol.121, issue.8, pp.1649-54, 2014. ,
DOI : 10.1016/j.ophtha.2014.02.003
Multicenter Study of Intravitreal Dexamethasone Implant in Noninfectious Uveitis: Indications, Outcomes, and Reinjection Frequency, American Journal of Ophthalmology, vol.158, issue.6, 2014. ,
DOI : 10.1016/j.ajo.2014.09.003
Intravitreal Dexamethasone Implant in Patients with Persistent Macular Edema of Variable Etiologies, Ophthalmologica, vol.232, issue.2, pp.83-91, 2014. ,
DOI : 10.1159/000360304
DEXAMETHASONE INTRAVITREAL IMPLANT FOR TREATMENT OF UVEITIC PERSISTENT CYSTOID MACULAR EDEMA IN VITRECTOMIZED PATIENTS, Retina, vol.33, issue.7, pp.1435-1475, 2013. ,
DOI : 10.1097/IAE.0b013e31827e247b
Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients. Retina Phila Pa, pp.915-938, 2011. ,
Dexamethasone Posterior-Segment Drug Delivery System in the Treatment of Macular Edema Resulting from Uveitis or Irvine-Gass Syndrome, American Journal of Ophthalmology, vol.147, issue.6, 2009. ,
DOI : 10.1016/j.ajo.2008.12.033
Dexamethasone intravitreal implant (Ozurdex) for the treatment of pediatric uveitis, J AAPOS. 2014, vol.18, issue.2, pp.110-113 ,
Treatment of refractory uveitic macular edema with dexamethasone intravitreal implants in a pediatric patient with bilateral granulomatous idiopathic panuveitis: a case report, Journal of Ophthalmic Inflammation and Infection, vol.3, issue.1, p.61, 2013. ,
DOI : 10.1167/iovs.10-5285